In a rare, longitudinal study, researchers from Aalto University and the University of Oulu tracked one person’s brain and behavioral activity for five months using brain scans and data from wearable devices and smartphones.
Recipharm’s new CEO on ‘fast and furious’ changes, with eyes on GLP-1, biologics manufacturing
Just over three months into his new role as the CEO of Recipharm, Greg Behar is already making sizable changes to the CDMO’s engine. “I’ve